Stock 002923 ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Zhuhai Rundu Pharmaceutical Co., Ltd. Stock

Equities

002923

CNE1000033G8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
10.78 CNY -1.28% Intraday chart for Zhuhai Rundu Pharmaceutical Co., Ltd. -2.27% -12.64%
May. 20 Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024 CI
Apr. 27 Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Financials

Sales 2022 1.37B 189M Sales 2023 1.29B 178M Capitalization 4.13B 570M
Net income 2022 155M 21.38M Net income 2023 66M 9.1M EV / Sales 2022 3.23 x
Net Debt 2022 247M 34.12M Net Debt 2023 288M 39.73M EV / Sales 2023 3.42 x
P/E ratio 2022
26.9 x
P/E ratio 2023
61.7 x
Employees 1,891
Yield 2022
2%
Yield 2023
-
Free-Float 33.52%
More Fundamentals * Assessed data

Chart Zhuhai Rundu Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news about Zhuhai Rundu Pharmaceutical Co., Ltd.

Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for 2023, Payable on 31 May 2024 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Rundu Pharmaceutical's Rabeprazole Sodium Tablets Chosen for China's Centralized Procurement MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Zhuhai Rundu Pharma Gets Supplementary Application Approval For Hypertension Drug MT
Rundu Pharmaceutical Gets Nod to Market Raw Drug Material MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend for 2022, Payable on 31 May 2023 CI
Tianyu Pharmaceutical Unit Gets Approval to Market Hypertension Drug in China MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Management Appointments CI
Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Rundu Pharmaceutical Unit Wins Drug Production License MT
Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Cash Dividend for the Year 2021 CI
More news

Quotes and Performance

1 day-1.28%
1 week-2.27%
Current month-0.74%
1 month+5.69%
3 months+21.26%
6 months-22.05%
Current year-12.64%
More quotes

Highs and lows

1 week
10.72
Extreme 10.72
11.12
1 month
10.60
Extreme 10.6
12.35
Current year
6.81
Extreme 6.81
13.67
1 year
6.81
Extreme 6.81
14.32
3 years
6.81
Extreme 6.81
22.25
5 years
6.81
Extreme 6.81
22.25
10 years
6.81
Extreme 6.81
22.25
More quotes

Managers and Directors - Zhuhai Rundu Pharmaceutical Co., Ltd.

Managers TitleAgeSince
Jie Liu CEO
 Chief Executive Officer 48 18-10-20
Shen Hua Shi DFI
 Director of Finance/CFO 61 11-04-15
Xin Min Chen CHM
 Chairman 58 11-04-15
Members of the board TitleAgeSince
Bo Wang BRD
 Director/Board Member 62 23-03-13
Xin Min Chen CHM
 Chairman 58 11-04-15
Zhi Jun Hua CHM
 Chairman 55 11-04-15
More insiders

Quotes

Date Price Change Volume
24-05-28 10.78 -1.28% 1,480,323
24-05-27 10.92 -0.73% 2,618,267
24-05-24 11 +1.57% 2,892,471
24-05-23 10.83 -1.37% 2,192,828
24-05-22 10.98 -0.45% 2,010,506

End-of-day quote Shenzhen S.E., May 27, 2024

More quotes

Company Profile

Zhuhai Rundu Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and sales of chemical medicine preparations, chemical medicine raw materials and pharmaceutical intermediates. The Company’s products cover the fields of cardio-cerebral blood vessels, digestion and anesthesia, among others.
Sector
Pharmaceuticals
Calendar
2024-08-22 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Stock Zhuhai Rundu Pharmaceutical Co., Ltd.
-12.64% 498M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+38.07% 727B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.35% 592B
JOHNSON & JOHNSON Stock Johnson & Johnson
-7.78% 347B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.03% 319B
ABBVIE INC. Stock AbbVie Inc.
+0.63% 274B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.28% 238B
NOVARTIS AG Stock Novartis AG
+6.73% 204B
ROCHE HOLDING AG Stock Roche Holding AG
-5.93% 203B
PFIZER, INC. Stock Pfizer, Inc.
-3.59% 160B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002923 Stock